Mehdi, S.; Macdonald, E.; Galpin, K.; Landry, D.A.; Rodriguez, G.; Vanderhyden, B.; Bachvarov, D.
LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model. Int. J. Mol. Sci. 2020, 21, 4992.
https://doi.org/10.3390/ijms21144992
AMA Style
Mehdi S, Macdonald E, Galpin K, Landry DA, Rodriguez G, Vanderhyden B, Bachvarov D.
LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model. International Journal of Molecular Sciences. 2020; 21(14):4992.
https://doi.org/10.3390/ijms21144992
Chicago/Turabian Style
Mehdi, Sadia, Elizabeth Macdonald, Kristianne Galpin, David A. Landry, Galaxia Rodriguez, Barbara Vanderhyden, and Dimcho Bachvarov.
2020. "LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model" International Journal of Molecular Sciences 21, no. 14: 4992.
https://doi.org/10.3390/ijms21144992
APA Style
Mehdi, S., Macdonald, E., Galpin, K., Landry, D. A., Rodriguez, G., Vanderhyden, B., & Bachvarov, D.
(2020). LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model. International Journal of Molecular Sciences, 21(14), 4992.
https://doi.org/10.3390/ijms21144992
